Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer
Authors
Keywords
Breast cancer, <em class=EmphasisTypeItalic >PTEN</em>, Triple negative
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 151, Issue 3, Pages 541-553
Publisher
Springer Nature
Online
2015-05-15
DOI
10.1007/s10549-015-3430-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Loss of PTEN Expression Is Associated With IGFBP2 Expression, Younger Age, and Late Stage in Triple-Negative Breast Cancer
- (2014) Sarah J. R. Dean et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment
- (2013) Y H Park et al. BRITISH JOURNAL OF CANCER
- Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues
- (2013) Oscar Maiques et al. HUMAN PATHOLOGY
- Comprehensive analysis of PTEN status in breast carcinomas
- (2013) Natalie Jones et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial
- (2013) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTEN
- (2013) Yanyuan Wu et al. PLoS One
- Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
- (2013) John Stagg et al. Therapeutic Advances in Medical Oncology
- Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
- (2012) F. Andre et al. ANNALS OF ONCOLOGY
- Effect of ASCO/CAP Guidelines for Determining ER Status on Molecular Subtype
- (2012) Brenda Deyarmin et al. ANNALS OF SURGICAL ONCOLOGY
- Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
- (2012) D. W. Craig et al. MOLECULAR CANCER THERAPEUTICS
- Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer
- (2011) E. Razis et al. BREAST CANCER RESEARCH AND TREATMENT
- MGMT and PTEN as potential prognostic markers in breast cancer
- (2011) Julio Cirullo Neto et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- PTEN, PIK3CA, p-AKT, and p-p70S6K Status
- (2010) Francisco J. Esteva et al. AMERICAN JOURNAL OF PATHOLOGY
- Protein expression profile and prevalence pattern of the molecular classes of breast cancer - a Saudi population based study
- (2010) Dalal M Al Tamimi et al. BMC CANCER
- Management of breast cancer with targeted agents: importance of heterogenicity
- (2010) Serena Di Cosimo et al. Nature Reviews Clinical Oncology
- Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma
- (2009) Alessandra Capodanno et al. HUMAN PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started